EVGN CIK: 1574565

Evogene Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
56.9
FY22:
37.8
FY23:
34.5
FY24:
21.6
FY25:
15.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
19.4
FY22:
18.4
FY23:
16.6
FY24:
18.3
FY25:
4.42
Total assets
Change from FY21 to FY25
millions USD
FY21:
76.3
FY22:
56.1
FY23:
51.1
FY24:
39.9
FY25:
20.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.88
FY22:
5.63
FY23:
6.94
FY24:
18.7
FY25:
3.44
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.00
FY22:
15.7
FY23:
15.5
FY24:
6.33
FY25:
4.63
(positive)
Change from FY21 to FY25
millions USD
FY21:
63.4
FY22:
34.8
FY23:
28.7
FY24:
14.8
FY25:
12.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
76.3
FY22:
56.1
FY23:
51.1
FY24:
39.9
FY25:
20.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data